Related Experiment Videos
Continuous intraventricular clonidine infusion in controlled morphine withdrawal--case report
M Lorenz1, S Hussein, L Verner
1Department of Neurosurgery, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany Department of Anesthesiology, Medizinische Hochschule Hannover, Hannover, Germany.
Pain
|July 20, 2002
Summary
This study shows that substituting clonidine for morphine can help patients with facial pain regain morphine effectiveness and improve quality of life. This approach allows for a drug holiday with minimal withdrawal symptoms.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Management
Background:
- Intracerebroventricular (ICV) morphine is used for intractable pain.
- Tolerance and adverse effects can limit long-term ICV morphine efficacy.
- Atypical facial pain presents unique management challenges.
Observation:
- A patient with atypical facial pain experienced loss of analgesic effect and severe side effects from continuous ICV morphine.
- Clonidine substitution was initiated over 3 weeks for a morphine drug holiday.
- The patient reported no significant withdrawal symptoms or major pain discomfort during the substitution period.
Findings:
- Morphine withdrawal using clonidine substitution led to improved analgesic efficacy of morphine.
- The patient required a significantly lower daily morphine dose six months post-treatment.
- Quality of life significantly improved without undesirable side effects.
Implications:
- Clonidine substitution is a viable strategy for managing opioid tolerance and side effects in patients with chronic pain.
- This approach can facilitate opioid dose reduction and improve patient outcomes.
- Further research is warranted to explore the broader application of this strategy in pain management.